2024 Q2 Form 10-Q Financial Statement

#000143462124000013 Filed on May 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $210.1M $167.8M $134.4M
YoY Change 15.17% -16.33% -33.51%
Cost Of Revenue $8.411M $8.545M $8.126M
YoY Change -9.58% -37.9% -39.94%
Gross Profit $201.7M $70.52M $126.2M
YoY Change 16.5% -11.8% -33.05%
Gross Profit Margin 96.0% 42.04% 93.95%
Selling, General & Admin $175.5M $134.0M $108.6M
YoY Change 20.85% -22.91% -37.29%
% of Gross Profit 87.0% 189.97% 86.07%
Research & Development $10.37M $11.86M $11.10M
YoY Change -2.14% -19.09% -15.52%
% of Gross Profit 5.14% 16.81% 8.79%
Depreciation & Amortization $6.068M $4.667M $6.513M
YoY Change -8.97% -2.67% -26.01%
% of Gross Profit 3.01% 6.62% 5.16%
Operating Expenses $191.9M $145.8M $126.3M
YoY Change 18.13% -22.62% -35.31%
Operating Profit $9.782M $7.179M -$32.00K
YoY Change -8.23% -155.18% -99.52%
Interest Expense -$1.201M -$6.638M $10.69M
YoY Change -82.69% -126.52% -277.51%
% of Operating Profit -12.28% -92.46%
Other Income/Expense, Net $1.052M $1.034M $2.644M
YoY Change -44.01% -43.62% 29.8%
Pretax Income $9.438M $1.575M $13.12M
YoY Change 8326.79% -88.63% -215.67%
Income Tax $1.686M $559.0K $397.0K
% Of Pretax Income 17.86% 35.49% 3.03%
Net Earnings $7.752M $1.016M $12.72M
YoY Change -6840.87% -92.45% -222.25%
Net Earnings / Revenue 3.69% 0.61% 9.47%
Basic Earnings Per Share $0.58 $0.08
Diluted Earnings Per Share $0.58 $0.08 $0.98
COMMON SHARES
Basic Shares Outstanding 13.22M shares 13.04M shares 13.00M shares
Diluted Shares Outstanding 13.41M shares 13.28M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $66.77M $230.7M $112.1M
YoY Change -58.95% 53.75% -62.51%
Cash & Equivalents $66.77M $230.7M $112.1M
Short-Term Investments
Other Short-Term Assets $31.46M $31.62M $29.48M
YoY Change 150.08% 11.87% -8.07%
Inventory
Prepaid Expenses
Receivables $107.7M $63.32M $54.95M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $205.9M $325.7M $196.5M
YoY Change -22.12% 24.31% -52.54%
LONG-TERM ASSETS
Property, Plant & Equipment $101.2M $48.30M $50.48M
YoY Change -16.31% -15.87% -14.67%
Goodwill $381.5M $381.5M $381.5M
YoY Change -9.19% -9.19% -9.19%
Intangibles $47.67M $49.13M $50.62M
YoY Change -12.19% -12.68% -13.2%
Long-Term Investments $60.08M $60.08M $60.08M
YoY Change -65.3% -65.59% -65.59%
Other Assets $5.746M $5.871M $6.339M
YoY Change -7.05% -7.09% 3.9%
Total Long-Term Assets $596.3M $601.0M $606.3M
YoY Change -23.03% -22.98% -22.8%
TOTAL ASSETS
Total Short-Term Assets $205.9M $325.7M $196.5M
Total Long-Term Assets $596.3M $601.0M $606.3M
Total Assets $802.2M $926.7M $802.8M
YoY Change -22.8% -11.09% -33.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.042M $3.097M $1.960M
YoY Change -4.16% -30.76% -3.45%
Accrued Expenses $95.17M $69.72M $70.54M
YoY Change 42.59% -17.81% -6.06%
Deferred Revenue $0.00
YoY Change -100.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $14.90M $14.90M $3.125M
YoY Change 495.8% 495.96% 25.0%
Total Short-Term Liabilities $113.1M $87.71M $75.63M
YoY Change 41.6% -4.45% -8.37%
LONG-TERM LIABILITIES
Long-Term Debt $467.7M $631.3M $525.6M
YoY Change -25.19% 0.96% -35.39%
Other Long-Term Liabilities $72.45M $278.0K $267.0K
YoY Change -14.71% -15.5% -13.31%
Total Long-Term Liabilities $540.2M $631.6M $525.9M
YoY Change -23.94% 0.95% -35.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $113.1M $87.71M $75.63M
Total Long-Term Liabilities $540.2M $631.6M $525.9M
Total Liabilities $656.4M $795.2M $678.6M
YoY Change -17.69% -1.99% -31.55%
SHAREHOLDERS EQUITY
Retained Earnings -$828.9M -$836.7M -$837.7M
YoY Change 18.09% 19.21% 17.11%
Common Stock $1.241B $1.234B $1.228B
YoY Change 2.57% 2.95% 3.25%
Preferred Stock
YoY Change
Treasury Stock (at cost) $266.2M $266.2M $266.2M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $145.8M $131.5M $124.1M
YoY Change
Total Liabilities & Shareholders Equity $802.2M $926.7M $802.8M
YoY Change -22.8% -11.09% -33.07%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $7.752M $1.016M $12.72M
YoY Change -6840.87% -92.45% -222.25%
Depreciation, Depletion And Amortization $6.068M $4.667M $6.513M
YoY Change -8.97% -2.67% -26.01%
Cash From Operating Activities -$4.943M $5.708M $20.88M
YoY Change -132.8% -56.61% 25.44%
INVESTING ACTIVITIES
Capital Expenditures $2.730M $2.746M $2.600M
YoY Change 13.7% 11.99% 5.14%
Acquisitions
YoY Change
Other Investing Activities $2.000K $50.00K
YoY Change 614.29%
Cash From Investing Activities -$2.728M -$2.746M -$2.550M
YoY Change 13.62% 11.99% 3.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -156.3M $115.7M -81.86M
YoY Change 156221.0% -172.54% 9254.97%
NET CHANGE
Cash From Operating Activities -4.943M $5.708M 20.88M
Cash From Investing Activities -2.728M -$2.746M -2.550M
Cash From Financing Activities -156.3M $115.7M -81.86M
Net Change In Cash -164.0M $118.7M -63.53M
YoY Change -1404.94% -179.74% -577.5%
FREE CASH FLOW
Cash From Operating Activities -$4.943M $5.708M $20.88M
Capital Expenditures $2.730M $2.746M $2.600M
Free Cash Flow -$7.673M $2.962M $18.28M
YoY Change -160.57% -72.33% 28.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
230979000 usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
8545000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
13760000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
108176000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
137111000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25796000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36683000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11857000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14655000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4667000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4795000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1489000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2049000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
23000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
4454000 usd
CY2024Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-36000 usd
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-12000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
160589000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
213519000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7179000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13011000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6638000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25029000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1034000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1834000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1575000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13852000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
559000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
395000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1016000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1016000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13457000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
13457000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13100000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12846000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13276000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12935000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
124132000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1016000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1016000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7789000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1422000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
131515000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
207940000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13457000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
13457000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11274000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1693000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
1000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
13457000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-368000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5027000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1489000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2049000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
4667000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
4795000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7789000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11274000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
128000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
360000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-129000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
963000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
612000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1959000 usd
CY2024Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 usd
CY2023Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2373000 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2024Q1 tree Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
-1007000 usd
CY2023Q1 tree Ro Uassetamortizationoffsetbychangeinoperatingleaseliabilities
ROUassetamortizationoffsetbychangeinoperatingleaseliabilities
-877000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
0 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
34308000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8235000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
211000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2034000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1882000 usd
CY2024Q1 tree Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
797000 usd
CY2023Q1 tree Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
8559000 usd
CY2024Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
86000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
42000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-155000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
424000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5708000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13156000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2746000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2452000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2746000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2452000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
125000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
625000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
625000 usd
CY2024Q1 tree Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
-1422000 usd
CY2023Q1 tree Proceeds Payments Related To Net Share Settlement Of Stock Based Compensation Net
ProceedsPaymentsRelatedToNetShareSettlementOfStockBasedCompensationNet
-1693000 usd
CY2024Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
156294000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4085000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
953000 usd
CY2024Q1 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
3125000 usd
CY2023Q1 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
115743000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-159565000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
118705000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-148861000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112056000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298969000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
230761000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150108000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is required to make certain estimates and assumptions during the preparation of the consolidated financial statements in accordance with GAAP. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. They also impact the reported amount of net earnings during any period. Actual results could differ from those estimates. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant estimates underlying the accompanying consolidated financial statements include: the recoverability of long-lived assets, goodwill and intangible assets; the determination of income taxes payable and deferred income taxes, including related valuation allowances; fair value of assets acquired in a business combination; litigation accruals; contract assets; various other allowances, reserves and accruals; assumptions related to the determination of stock-based compensation; and the determination of right-of-use assets and lease liabilities. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the impact of the current economic conditions, including interest rates and inflation on the assumptions and estimates used when preparing its consolidated financial statements including, but not limited to, the allowance for doubtful accounts, valuation allowances, contract asset, and the recoverability of long-lived assets, goodwill and intangible assets. These assumptions and estimates may change as new events occur and additional information is obtained. If economic conditions worsen, such future changes may have an adverse impact on the Company's results of operations, financial position and liquidity.</span></div>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Risks and Concentrations</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LendingTree's business is subject to certain risks and concentrations including dependence on third-party technology providers, exposure to risks associated with online commerce security and fraud.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk at March 31, 2024, consist primarily of cash and cash equivalents and accounts receivable, as disclosed in the consolidated balance sheet. Cash and cash equivalents are in excess of Federal Deposit Insurance Corporation insurance limits, but are maintained with quality financial institutions of high credit. The Company requires certain Network Partners to maintain security deposits with the Company, which in the event of non-payment, would be applied against any accounts receivable outstanding.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the nature of the mortgage lending industry, interest rate fluctuations may negatively impact future revenue from the Company's marketplace.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lenders and lead purchasers participating on the Company's marketplace can offer their products directly to consumers through brokers, mass marketing campaigns or through other traditional methods of credit distribution. These lenders and lead purchasers can also offer their products online, either directly to prospective borrowers, through one or more online competitors, or both. If a significant number of potential consumers are able to obtain loans and other products from Network Partners without utilizing the Company's services, the Company's ability to generate revenue may be limited. Because the Company does not have exclusive relationships with the Network Partners whose loans and other financial products are offered on its online marketplace, consumers may obtain offers from these Network Partners without using its service.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than a support services office in India, the Company's operations are geographically limited to and dependent upon the economic condition of the United States.</span></div>
CY2024Q1 us-gaap Revenues
Revenues
167768000 usd
CY2023Q1 us-gaap Revenues
Revenues
200508000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
15100000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
13700000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
800000 usd
CY2024Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
300000 usd
CY2023Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
200000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
230745000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112051000 usd
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
16000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
230761000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112056000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2222000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2317000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-129000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
963000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
67000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
963000 usd
CY2024Q1 tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
0 usd
CY2023Q1 tree Accounts Receivable Transfer To Held For Sale Valuation Allowance Expense
AccountsReceivableTransferToHeldForSaleValuationAllowanceExpense
371000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2026000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2688000 usd
CY2024Q1 us-gaap Goodwill Gross
GoodwillGross
903227000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
903227000 usd
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
521688000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
521688000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
381539000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
381539000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10142000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
10142000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38990000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40478000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
49132000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50620000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
76100000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37110000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38990000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
77400000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
36922000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40478000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4401000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5830000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5504000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5198000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4685000 usd
CY2024Q1 tree Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
13372000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38990000 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
113100000 usd
CY2024Q1 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
37334000 usd
CY2023Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
27859000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8072000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15091000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
816000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1101000 usd
CY2024Q1 tree Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
7113000 usd
CY2023Q4 tree Customer Depositsand Escrows Current
CustomerDepositsandEscrowsCurrent
7732000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6637000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7387000 usd
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9745000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11374000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
69717000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
70544000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13100000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12846000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
61000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
54000 shares
CY2024Q1 tree Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
115000 shares
CY2023Q1 tree Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
35000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13276000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12935000 shares
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
96700000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7789000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11274000 usd
CY2024Q1 us-gaap Share Price
SharePrice
42.34
CY2024Q1 us-gaap Share Price
SharePrice
42.34
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
559000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
395000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.355
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.029
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000 usd
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000 usd
CY2024Q1 us-gaap Litigation Reserve
LitigationReserve
700000 usd
CY2023Q4 us-gaap Litigation Reserve
LitigationReserve
600000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Revenues
Revenues
167768000 usd
CY2024Q1 us-gaap Marketing Expense
MarketingExpense
97246000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
70522000 usd
CY2024Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
8545000 usd
CY2024Q1 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
10930000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25796000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11857000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4667000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1489000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
23000 usd
CY2024Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-36000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7179000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6638000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1034000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1575000 usd
CY2023Q1 us-gaap Revenues
Revenues
200508000 usd
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
120551000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
79957000 usd
CY2023Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
13760000 usd
CY2023Q1 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
16560000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36683000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14655000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4795000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2049000 usd
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
4454000 usd
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-12000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13011000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25029000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1834000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13852000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001434621-24-000013-index-headers.html Edgar Link pending
0001434621-24-000013-index.html Edgar Link pending
0001434621-24-000013.txt Edgar Link pending
0001434621-24-000013-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_153a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tree-20240331.htm Edgar Link pending
tree-20240331.xsd Edgar Link pending
tree-20240331_g1.jpg Edgar Link pending
tree-20240331_g2.jpg Edgar Link pending
tree-2024331x10qexx102.htm Edgar Link pending
tree-2024331x10qexx311.htm Edgar Link pending
tree-2024331x10qexx312.htm Edgar Link pending
tree-2024331x10qexx321.htm Edgar Link pending
tree-2024331x10qexx322.htm Edgar Link pending
tree-20240331_def.xml Edgar Link unprocessable
tree-20240331_lab.xml Edgar Link unprocessable
tree-20240331_htm.xml Edgar Link completed
tree-20240331_pre.xml Edgar Link unprocessable
tree-20240331_cal.xml Edgar Link unprocessable